MYC and neoplasm: Pyruvate kinase M2 (PKM2), a glycolysis enzyme, phosphorylates histone H3 causing dissociation of HDAC3 from CCND1 and the MYC promoter region, thereby increasing their expression, tumor cell proliferation, cell cycle progression, and brain tumor formation.